Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)

[1]  Deborah S. Barkauskas,et al.  Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity , 2016, Science.

[2]  I. Pollack,et al.  MB-94IMMUNOLOGIC PROFILE OF PATIENTS WITH NEWLY-DIAGNOSED MEDULLOBLASTOMA AT INITIAL DIAGNOSIS AND DURING STANDARD RADIATION AND CHEMOTHERAPY (PBTC-N11) , 2016 .

[3]  Z. Amoura,et al.  Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus , 2015, PloS one.

[4]  L. Coussens,et al.  Immune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistance. , 2015, Trends in cancer.

[5]  Christopher M. Jackson,et al.  Immunotherapy for Brain Cancer: Recent Progress and Future Promise , 2014, Clinical Cancer Research.

[6]  C. Yee,et al.  The Effect of Radiation on the Immune Response to Cancers , 2014, International journal of molecular sciences.

[7]  Daofeng Liu,et al.  Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. , 2013, Clinical immunology.

[8]  D. Wainwright,et al.  Targeting Tregs in Malignant Brain Cancer: Overcoming IDO , 2013, Front. Immunol..

[9]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[10]  David E. Anderson,et al.  Medulloblasoma: challenges for effective immunotherapy , 2012, Journal of Neuro-Oncology.

[11]  J. Lederer,et al.  Targeting regulatory T cells in cancer. , 2011, Cancer research.

[12]  D. Mougiakakos,et al.  Camouflage and sabotage: tumor escape from the immune system , 2011, Cancer Immunology, Immunotherapy.

[13]  D. Schadendorf,et al.  Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  P. Zhou,et al.  The Role of T-Helper 17 (Th17) Cells in Patients with Medulloblastoma , 2010, The Journal of international medical research.

[15]  R. McLendon,et al.  Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. , 2008, Neuro-oncology.

[16]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[17]  G. Fuller,et al.  The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. , 2008, Clinical neurosurgery.

[18]  G. Basso,et al.  Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. , 2007, Cancer research.

[19]  J. McCune,et al.  Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. , 2007, Journal of immunological methods.

[20]  T. Merchant,et al.  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.

[21]  W. Zou,et al.  Regulatory T-cell compartmentalization and trafficking. , 2006, Blood.

[22]  A. Friedman,et al.  Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. , 2006, Cancer research.

[23]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[24]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[25]  J. Ashwell,et al.  Glucocorticoids in T cell development and function*. , 2000, Annual review of immunology.